Using real-world data to assess comparative effectiveness and safety of apixaban and rivaroxaban in patients with nonvalvular atrial fibrillation in the UK
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY(2022)